Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Nanwujia Oral Liquid (fufang nanwujia koufuye) is a Traditional Chinese Medicine (TCM) developed and manufactured by Hunan Jiudian Pharmaceutical. It is an oral liquid formulation primarily indicated for the treatment of fatigue, immune support, and symptoms associated with spleen and kidney deficiency, such as insomnia and loss of appetite. The preparation is centered around the root bark of *Acanthopanax gracilistylus* (Nanwujia), which contains eleutherosides and other bioactive compounds recognized for their adaptogenic and immunomodulatory properties. As a compound formulation, it integrates multiple herbal ingredients to provide a synergistic effect on vitality and physical recovery. It is approved by the NMPA in China as a pharmaceutical product for these indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fufang nanwujia koufuye.